2017-2025 World Duchenne Muscular Dystrophy Market Research Report (by Product Type, End-User/Application and Regions/Countries)

December 2019 | 105 pages | ID: 2FB6627E39B0EN
HeyReport

Abstracts

SUMMARY

Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Duchenne Muscular Dystrophy , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Duchenne Muscular Dystrophy market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• Deflazacort
• Prednisone
• Others

By End-User / Application

• Male
• Female

By Company

• PTC Therapeutics
• Sarepta Therapeutics
• Bristol-Myers Squibb
• ITALFARMACO
• BioMarin
• Daiichi Sankyo
• Solid Biosciences
• Summit Therapeutics
• FibroGen
• NS Pharma
• Pfizer
• ReveraGen BioPharma
• Wave Life
• Genethon
• Santhera Pharmaceuticals

Contents

1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use / Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use / Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS

12.SMITH & NEPHEW PTC THERAPEUTICS

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Sarepta Therapeutics
12.3 Bristol-Myers Squibb
12.4 ITALFARMACO
12.5 BioMarin
12.6 Daiichi Sankyo
12.7 Solid Biosciences
12.8 Summit Therapeutics
12.9 FibroGen
12.10 NS Pharma
12.11 Pfizer
12.12 ReveraGen BioPharma
12.13 Wave Life
12.14 Genethon
12.15 Santhera Pharmaceuticals

13 PRICE OVERVIEW

13.1 Price Segment
13.2 Price Trend

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Duchenne Muscular Dystrophy Market and Growth by Type
Table Global Duchenne Muscular Dystrophy Market and Growth by End-Use / Application
Table Global Duchenne Muscular Dystrophy Revenue (Million USD) by Vendors (2017-2019)
Table Global Duchenne Muscular Dystrophy Revenue Share by Vendors (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume (Volume) by Vendors (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Duchenne Muscular Dystrophy Market (Million USD) by Type (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Share by Type (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume (Volume) by Type (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume Share by Type (2017-2019)
Table Global Duchenne Muscular Dystrophy Market (Million USD) by End-Use / Application (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Share by End-Use / Application (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume Share by End-Use / Application (2017-2019)
Table Global Duchenne Muscular Dystrophy Market (Million USD) by Regions (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Share by Regions (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume (Volume) by Regions (2017-2019)
Table Global Duchenne Muscular Dystrophy Market Volume Share by Regions (2017-2019)
Table North America Duchenne Muscular Dystrophy Market (Million USD) by Type (2017-2019)
Table North America Duchenne Muscular Dystrophy Market Share by Type (2017-2019)
Table North America Duchenne Muscular Dystrophy Market (Million USD) by End-Use / Application (2017-2019)
Table North America Duchenne Muscular Dystrophy Market Share by End-Use / Application (2017-2019)
Table North America Duchenne Muscular Dystrophy Market (Million USD) by Regions (2017-2019)
Table North America Duchenne Muscular Dystrophy Market Share by Regions (2017-2019)
Table Europe Duchenne Muscular Dystrophy Market (Million USD) by Type (2017-2019)
Table Europe Duchenne Muscular Dystrophy Market Share by Type (2017-2019)
Table Europe Duchenne Muscular Dystrophy Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Duchenne Muscular Dystrophy Market Share by End-Use / Application (2017-2019)
Table Europe Duchenne Muscular Dystrophy Market (Million USD) by Regions (2017-2019)
Table Europe Duchenne Muscular Dystrophy Market Share by Regions (2017-2019)
Table Asia-Pacific Duchenne Muscular Dystrophy Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Duchenne Muscular Dystrophy Market Share by Type (2017-2019)
Table Asia-Pacific Duchenne Muscular Dystrophy Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Duchenne Muscular Dystrophy Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Duchenne Muscular Dystrophy Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Duchenne Muscular Dystrophy Market Share by Regions (2017-2019)
Table South America Duchenne Muscular Dystrophy Market (Million USD) by Type (2017-2019)
Table South America Duchenne Muscular Dystrophy Market Share by Type (2017-2019)
Table South America Duchenne Muscular Dystrophy Market (Million USD) by End-Use / Application (2017-2019)
Table South America Duchenne Muscular Dystrophy Market Share by End-Use / Application (2017-2019)
Table South America Duchenne Muscular Dystrophy Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Share by Regions (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Share by Type (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Share by Regions (2017-2019)
Table Global Duchenne Muscular Dystrophy Market (Million USD) Forecast by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Market Share Forecast by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Market Volume Share Forecast by Regions (2020-2025)
Table Global Duchenne Muscular Dystrophy Market (Million USD) Forecast by Type (2020-2025)
Table Global Duchenne Muscular DystrophyMarket Share by Forecast Type (2020-2025)
Table Global Duchenne Muscular Dystrophy Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Duchenne Muscular Dystrophy Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of PTC Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Sarepta Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of ITALFARMACO
Table Sales Revenue, Volume, Price, Cost and Margin of BioMarin
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo
Table Sales Revenue, Volume, Price, Cost and Margin of Solid Biosciences
Table Sales Revenue, Volume, Price, Cost and Margin of Summit Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of FibroGen
Table Sales Revenue, Volume, Price, Cost and Margin of NS Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of ReveraGen BioPharma
Table Sales Revenue, Volume, Price, Cost and Margin of Wave Life
Table Sales Revenue, Volume, Price, Cost and Margin of Genethon
Table Sales Revenue, Volume, Price, Cost and Margin of Santhera Pharmaceuticals

List Of Figures

LIST OF FIGURES

Figure Global Duchenne Muscular Dystrophy Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Duchenne Muscular Dystrophy Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Duchenne Muscular Dystrophy Market Volume (Volume) and Growth Forecast (2020-2025)